Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -7.32%139.65M | -15.64%287.32M | -19.94%150.67M | -17.02%340.58M | -14.23%188.2M | -18.12%410.42M | -15.57%219.42M | 9.84%501.27M | 18.27%259.89M | -1.06%456.37M |
| Operating income | -7.32%139.65M | -15.64%287.32M | -19.94%150.67M | -17.02%340.58M | -14.23%188.2M | -18.12%410.42M | -15.57%219.42M | 9.84%501.27M | 18.27%259.89M | -1.06%456.37M |
| Cost of sales | 9.26%-99.44M | 15.53%-212.11M | 19.30%-109.59M | 17.50%-251.09M | 15.73%-135.8M | 17.64%-304.34M | 14.92%-161.16M | -6.63%-369.5M | -15.40%-189.42M | 3.37%-346.52M |
| Operating expenses | 9.26%-99.44M | 15.53%-212.11M | 19.30%-109.59M | 17.50%-251.09M | 15.73%-135.8M | 17.64%-304.34M | 14.92%-161.16M | -6.63%-369.5M | -15.40%-189.42M | 3.37%-346.52M |
| Gross profit | -2.12%40.21M | -15.95%75.22M | -21.60%41.08M | -15.64%89.49M | -10.07%52.4M | -19.49%106.08M | -17.31%58.27M | 19.95%131.77M | 26.73%70.47M | 7.04%109.85M |
| Selling expenses | 3.13%-13.42M | -4.39%-30.37M | 7.30%-13.85M | 7.70%-29.09M | 12.35%-14.94M | 10.40%-31.52M | 7.96%-17.05M | -2.88%-35.18M | -11.99%-18.52M | 5.29%-34.19M |
| Administrative expenses | 9.08%-27.1M | -1.64%-53.74M | 11.15%-29.8M | 20.69%-52.88M | 11.17%-33.54M | 3.83%-66.67M | -5.59%-37.76M | -8.62%-69.32M | -4.43%-35.76M | 2.36%-63.82M |
| Special items of operating profit | -48.77%686K | 1.13%2.77M | -40.33%1.34M | -51.56%2.74M | -54.89%2.24M | 101.39%5.66M | 362.79%4.98M | -75.33%2.81M | -85.35%1.08M | 187.18%11.4M |
| Operating profit | 130.37%376K | -159.65%-6.12M | -120.11%-1.24M | -24.29%10.26M | -27.00%6.16M | -54.93%13.56M | -51.14%8.43M | 29.43%30.08M | 41.97%17.26M | 352.83%23.24M |
| Financing cost | 38.39%-886K | 28.86%-2.75M | 33.02%-1.44M | 10.56%-3.87M | -54.13%-2.15M | -63.78%-4.33M | -48.03%-1.39M | 2.15%-2.64M | 31.26%-941K | 24.31%-2.7M |
| Earning before tax | 80.94%-510K | -238.80%-8.88M | -166.77%-2.68M | -30.73%6.39M | -43.05%4.01M | -66.36%9.23M | -56.86%7.04M | 33.58%27.44M | 51.26%16.32M | 1,212.40%20.54M |
| Tax | -2.55%-2.21M | 65.43%-1.61M | 29.56%-2.16M | -17.22%-4.64M | -77.61%-3.06M | 37.09%-3.96M | 51.87%-1.72M | -222.87%-6.3M | -182.05%-3.58M | 59.49%-1.95M |
| After-tax profit from continuing operations | 43.68%-2.72M | -698.52%-10.48M | -610.89%-4.83M | -66.77%1.75M | -82.20%946K | -75.08%5.27M | -58.27%5.31M | 13.72%21.14M | 33.81%12.73M | 672.15%18.59M |
| Earning after tax | 43.68%-2.72M | -698.52%-10.48M | -610.89%-4.83M | -66.77%1.75M | -82.20%946K | -75.08%5.27M | -58.27%5.31M | 13.72%21.14M | 33.81%12.73M | 672.15%18.59M |
| Minority profit | 63.82%249K | -80.67%1.28M | -95.30%152K | 17.62%6.64M | 18.63%3.24M | -28.78%5.65M | -49.82%2.73M | 23.16%7.93M | 150.18%5.43M | 159.60%6.44M |
| Profit attributable to shareholders | 40.40%-2.97M | -140.52%-11.76M | -117.78%-4.99M | -1,193.92%-4.89M | -188.48%-2.29M | -102.86%-378K | -64.56%2.59M | 8.72%13.21M | -0.61%7.3M | 312.10%12.15M |
| Basic earnings per share | 40.00%-0.015 | -140.00%-0.0588 | -127.27%-0.025 | -1,189.47%-0.0245 | -184.62%-0.011 | -102.87%-0.0019 | -63.89%0.013 | 8.72%0.0661 | -2.70%0.036 | 312.59%0.0608 |
| Diluted earnings per share | 40.00%-0.015 | -140.00%-0.0588 | -127.27%-0.025 | -1,189.47%-0.0245 | -184.62%-0.011 | -102.87%-0.0019 | -63.89%0.013 | 8.72%0.0661 | -2.70%0.036 | 312.59%0.0608 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.